Home
 /
Papers
 /
Cell Biology
 /
A minor muscle stem cell population functions as metabolic Trojan horse fueling systemic aging by succinate induced epigenetic reprogramming
Preprint
Open access
Top 1% · Validated by QED

A minor muscle stem cell population functions as metabolic Trojan horse fueling systemic aging by succinate induced…

Xiaofen Wu, Meng Chen, Ruqi Fan +8 more
December 2025
 ·
bioRxiv
 ·
DOI 
10.64898/2025.12.26.696560
99
%
QED Score
QED Impressions

This work overturns the assumption that stem cell dysfunction is locally contained, showing a rare Tet2-deficient muscle stem cell pool propagates systemic inflammaging through succinate transfer and H4K31 succinylation, exposing new rejuvenation targets.

Run full QED analysis
Read paper
Save

QED claims analysis

Summary

Age-related Tet2 downregulation in muscle stem cells triggers systemic inflammaging and multi-organ aging through a metabolic-epigenetic cascade in which disruption of the Tet2-Hdac11-Acod1-SDH axis causes succinate accumulation that drives H4K31 succinylation-mediated inflammatory gene activation, and sporadic fusion of these metabolically dysregulated stem cells during muscle homeostasis delivers excess succinate to myofibers, transforming skeletal muscle into a persistent source of pro-inflammatory signals that sustains whole-body chronic inflammation and accelerates aging across multiple organs.

See full analysis
Main Claim 1 –

MuSC Tet2 Loss Drives Premature Multi-Organ Aging

Supporting evidence

  • Tet2 KO Impairs SDH Complex II, Causing MuSC Succinate Buildup
  • Tet2–Hdac11–Acod1 Disruption Elevates Succinate in Tet2-KO MuSCs
  • Citraconate Lowers Succinate and Reverses Tet2-KO Aging Phenotypes
Main Claim 2 –

Tet2-KO MuSC Fusion Transfers Succinate, Igniting Muscle Inflammation

Supporting evidence

  • Succinate-Induced H4K31succ Activates Pro-Inflammatory Genes in MuSCs
Main Claim 3 –

Age-Related MuSC Tet2 Decline Triggers Systemic Inflammaging

Abstract

Inflammaging, the sustained chronic inflammation, is a hallmark of aging, yet its sustained activation mechanism remains elusive. Here, we identified muscle stem cells (MuSCs) as a driver of systemic inflammaging, evidenced by the multi-organ inflammation and aging phenotypes in MuSC specific Tet2 knockout mice. Tet2-Hdac11-Acod1-SDH axis maintained normal succinate level in MuSCs. Tet2 knockout disrupted this enzymatic cascade and led to succinate accumulation, fueling H4K31succ elevation to directly activate inflammatory gene transcription in MuSCs. The excess succinate was delivered to muscle fibers by sporadic fusion of Tet2 knockout MuSCs during muscle homeostasis, activated pro-inflammatory program, and transformed muscle to a persistent pro-inflammatory factor secretory organ, sustaining systemic inflammaging. Moreover, Tet2 was downregulated in aged MuSCs suggesting that this coupled metabolic-epigenetic mechanism was active in physiological aging. These findings reveal that a small subset of dysregulated MuSCs activate sustained whole-body inflammaging and multi-organ aging, providing new targets for rejuvenation strategy development.

Related papers

How the QED Score works

QED Score is an AI-based quality metric for life science research. It rates each paper on two dimensions: originality (is the finding new and important?) and validity (does the evidence support the claims?). Author names and affiliations are removed before scoring. Each manuscript is broken down into its claims and the experiments behind them, and specialized AI agents then examine those claims for statistical rigor, consistency across figures, and contradictions with the existing literature. A verification layer re-checks every issue they flag. Scores are percentile ranks against all papers in the corpus. In a blinded study of papers where QED Score and journal rank disagreed, domain experts sided with QED Score in 75% of cases.
Read the methodology

Free access for academic researchers

Create your free QED account to validate your research, strengthen grant proposals, and uncover scientific insights.
We've sent you an access link.
Please check your inbox.

Didn't get your email? Check your spam folder or reach out to info@qedscience.com

Oops! Something went wrong while submitting the form.
Looking for QED for pharma, biotech or life science organizations?